Organigram Global Inc. (OGI)
NASDAQ: OGI · Real-Time Price · USD
1.440
-0.030 (-2.04%)
At close: Mar 9, 2026, 4:00 PM EDT
1.450
+0.010 (0.69%)
After-hours: Mar 9, 2026, 5:29 PM EDT
Organigram Global Revenue
Organigram Global had revenue of 63.54M CAD in the quarter ending December 31, 2025, with 48.70% growth. This brings the company's revenue in the last twelve months to 279.99M, up 68.55% year-over-year. In the fiscal year ending September 30, 2025, Organigram Global had annual revenue of 259.18M with 62.15% growth.
Revenue (ttm)
279.99M CAD
Revenue Growth
+68.55%
P/S Ratio
0.98
Revenue / Employee
246,254 CAD
Employees
1,137
Market Cap
199.47M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 259.18M | 99.34M | 62.15% |
| Sep 30, 2024 | 159.84M | 10.64M | 7.13% |
| Sep 30, 2023 | 149.21M | 3.40M | 2.33% |
| Aug 31, 2022 | 145.81M | 66.65M | 84.19% |
| Aug 31, 2021 | 79.16M | -7.63M | -8.79% |
| Aug 31, 2020 | Pro | Pro | Pro |
| Aug 31, 2019 | Pro | Pro | Pro |
| Aug 31, 2018 | Pro | Pro | Pro |
| Aug 31, 2017 | Pro | Pro | Pro |
| Aug 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Organogenesis Holdings | 564.17M |
| Evolus | 297.18M |
| Aurora Cannabis | 272.13M |
| Akebia Therapeutics | 236.20M |
| SIGA Technologies | 172.25M |
| Lifecore Biomedical | 128.87M |
| Anika Therapeutics | 112.82M |
| Journey Medical | 59.40M |
OGI News
- 4 days ago - Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity - Business Wire
- 10 days ago - 3 Canadian Marijuana Stocks To Diversify Your Stock Portfolio - MarijuanaStocks
- 13 days ago - Organigram (OGI) Expands Product Line in Australia with New Launch - GuruFocus
- 13 days ago - Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia - Business Wire
- 18 days ago - What's Going On With Organigram Global Stock Thursday? - Benzinga
- 18 days ago - Organigram (OGI) Gains on C$65.2M Investment from British American Tobacco - GuruFocus
- 18 days ago - Organigram gets C$65.2M BAT investment for Sanity - Seeking Alpha
- 18 days ago - Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group - Business Wire